Publication Name	World Journal of Gastroenterology
Manuscript ID	81702
Country	Italy

Received	2022-11-20 11:31
Peer-Review Started	2022-11-20 11:32
To Make the First Decision
Return for Revision	2023-01-02 21:29
Revised	2023-01-12 18:18
Second Decision	2023-03-06 03:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-03-14 18:41
Articles in Press	2023-03-14 18:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-20 11:56
Publish the Manuscript Online	2023-03-28 12:59

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Autoimmune liver diseases and SARS-CoV-2
Manuscript Source	Invited Manuscript
All Author List	Costantino Sgamato, Alba Rocco, Debora Compare, Stefano Minieri, Stefano Andrea Marchitto, Simone Maurea and Gerardo Nardone
Funding Agency and Grant Number
Corresponding Author	Alba Rocco, PhD, Doctor, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via S. Pansini, 5, Naples 80131, Italy. a.rocco@unina.it
Key Words	Autoimmune liver disease; SARS-CoV-2; COVID-19; COVID-19 vaccine; Autoimmune hepatitis
Core Tip	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a possible trigger of autoimmunity. Patients with autoimmune liver diseases (AILDs) were considered at higher risk of SARS-CoV-2 infection and more susceptible to severe coronavirus disease 2019 (COVID-19) due to genetic background and immunosuppressive treatments. Case reports documenting autoimmune hepatitis-like syndromes after the COVID vaccine started to emerge, raising worries about a possible risk of unwanted immunological side effects, especially in individuals predisposed to autoimmune disorders. We herein discuss the consequences of SARS-CoV-2 infection in patients with AILDs and the role of the vaccines in inducing liver autoimmunity.
Publish Date	2023-03-28 12:59
Citation	Sgamato C, Rocco A, Compare D, Minieri S, Marchitto SA, Maurea S, Nardone G. Autoimmune liver diseases and SARS-CoV-2. World J Gastroenterol 2023; 29(12): 1838-1851
URL	https://www.wjgnet.com/1007-9327/full/v29/i12/1838.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i12.1838

Full Article (PDF)	WJG-29-1838.pdf
Full Article (Word)	WJG-29-1838.docx
Manuscript File	81702_Auto_Edited-LM.docx
Answering Reviewers	81702-Answering reviewers.pdf
Audio Core Tip	81702-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	81702-Conflict-of-interest statement.pdf
Copyright License Agreement	81702-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	81702-Language certificate.pdf
Peer-review Report	81702-Peer-review(s).pdf
Scientific Misconduct Check	81702-Bing-Fan JR-2.png
Scientific Editor Work List	81702-Scientific editor work list.pdf